| 1 |
33091827 | A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer. | 2021 Jan |
1 |
| 2 |
26650486 | The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient. | 2016 Sep |
1 |
| 3 |
26842788 | Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance. | 2016 Mar |
1 |
| 4 |
26000095 | Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma. | 2015 Mar |
1 |
| 5 |
26200905 | Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy. | 2015 |
1 |
| 6 |
26323924 | The genotype of ribonucleotidereductase M1 -269C > A is associated with the response to platinum-based chemotherapy and as a prognostic biomarker in advanced nonsmall cell lung cancer. | 2015 Aug |
6 |
| 7 |
26715866 | Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy. | 2015 |
1 |
| 8 |
24155212 | Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy. | 2014 Mar |
3 |
| 9 |
24647522 | Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression. | 2014 |
1 |
| 10 |
25078585 | Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer. | 2014 Jul 24 |
1 |
| 11 |
25227663 | Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy. | 2014 Dec |
1 |
| 12 |
23401439 | ERCC1 and RRM1: ready for prime time? | 2013 Mar 10 |
1 |
| 13 |
23982437 | Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients. | 2013 Nov |
2 |
| 14 |
24045016 | Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer. | 2013 Nov |
2 |
| 15 |
22330686 | The potential of exploiting DNA-repair defects for optimizing lung cancer treatment. | 2012 Feb 14 |
1 |
| 16 |
28920258 | Response to gemcitabine-platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non-small-cell lung cancer. | 2012 Feb |
1 |
| 17 |
21370501 | RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum. | 2011 Mar |
4 |
| 18 |
19304340 | Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer. | 2009 Dec |
1 |
| 19 |
19552012 | [ERCC1 and RRM1 genes in lung cancer]. | 2009 Jul-Aug |
1 |
| 20 |
20719132 | [Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage I-II Lung Cancer.]. | 2009 May 20 |
1 |
| 21 |
18494946 | mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. | 2008 Jun |
3 |
| 22 |
18520795 | Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study. | 2008 Jun |
1 |
| 23 |
16966686 | RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. | 2006 Oct 10 |
2 |